ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: EC:3.4.19.12; Neuron cytoplasmic protein 9.5; PGP9.5; UCH-L1; Ubiquitin carboxyl-terminal hydrolase isozyme L1; Ubiquitin thioesterase L1
Storage: 2-8C
Application: Quality Control TestingWestern Blotting Analysis: A 1:1,000 dilution of this antibody detected PGP9.5/UCHL1 in SH-SY5Y cell lysate.Tested applicationsWestern Blotting Analysis: A 1:1,000 dilution from a representative lot detected PGP9.5/UCHL1 in Human brain, mouse brain, rat brain tissue lysates and PC12 cell lysate.Affinity Binding Assay: A representative lot of this antibody bound PGP9.5 peptides with a KD of 7.5 x 10-8 in an affinity binding assay.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected PGP9.5/UCHL1 in human pancreas tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected PGP9.5/UCHL1 in SH-SY5Y cells.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany